ChemicalBook > CAS DataBase List > Tofacitinib Impurity
Tofacitinib Impurity
- Product Name
- Tofacitinib Impurity
- CAS No.
- 2504210-41-5
- Chemical Name
- Tofacitinib Impurity
- Synonyms
- Azilsartan medoxomil impurity331;N-((3R,4R)-4-methyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine;1,3-Bis((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)propane-1,3-dione? (Tofacitinib Impurity)
- CBNumber
- CB98377989
- Molecular Formula
- C29H38N10O2
- Formula Weight
- 558.69
- MOL File
- 2504210-41-5.mol
More
Less
Tofacitinib Impurity Property
- Density
- 1.339±0.06 g/cm3(Predicted)
- pka
- 10.59±0.60(Predicted)
Tofacitinib Impurity Preparation Products And Raw materials
Raw materials
Preparation Products
More
Less
Tofacitinib Impurity Suppliers
- Tel
- 010-010-52878169 15801002657
- sales@bjcomparison.com
- Country
- China
- ProdList
- 4718
- Advantage
- 58
- Tel
- 021-64609169 18901607656
- Fax
- 021-64609160
- greensnown@163.com
- Country
- China
- ProdList
- 9906
- Advantage
- 50
- Tel
- 15633056635
- 2880679888@qq.com
- Country
- China
- ProdList
- 2967
- Advantage
- 58
- Tel
- 15374522761
- Fax
- QQ:2853117752
- 3003392093@qq.com
- Country
- China
- ProdList
- 8706
- Advantage
- 55
- Tel
- 020-61855200 13326451905
- 260366801@qq.com
- Country
- China
- ProdList
- 7812
- Advantage
- 58
- Tel
- 0531-88987162 18615427082
- 2823799053@qq.com
- Country
- China
- ProdList
- 491
- Advantage
- 58
- Tel
- 0510-85629785 18013409632
- Fax
- 0510-85625359
- sales@reading-chemicals.com
- Country
- China
- ProdList
- 14081
- Advantage
- 58
- Tel
- 0755-0755-0755-83725350 13380397412
- Fax
- 0755-28094224
- 3001280422@qq.com
- Country
- China
- ProdList
- 10005
- Advantage
- 58
- Tel
- 0757-85921206 18520245316
- 2329783215@qq.com
- Country
- China
- ProdList
- 12661
- Advantage
- 58
- Tel
- 0755-66853366; 13670046396
- ORDERS@QCSRM.COM
- Country
- China
- ProdList
- 24342
- Advantage
- 58
2504210-41-5, Tofacitinib ImpurityRelated Search:
2-Pentenoic acid, 3-amino-2-cyano-5-[(3R,4R)-4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidinyl]-5-oxo-, ethyl ester, (2E)-
Tofacitinib Impurity 6
Tofacitinib citrate
TF-A
(3R,4R)-3-[(6-amino-4-pyrimidinyl)methylamino]-4-methyl-β-oxo-1-Piperidinepropanenitrile
7H-Pyrrolo[2,3-d]pyrimidine, 4-hydrazinyl-
(3S,4S)-Tofacitinib
Tofacitinib impurity T
7H-Pyrrolo[2,3-d]pyrimidin-4-amine, N-methyl-N-[(3R,4R)-4-methyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-3-piperidinyl]-
Tofacitinib Impurity 45
1-Piperidinepropanenitrile, 4-Methyl-3-(Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMino)-β-oxo-
3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanoic acid
(3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidine-1-carbaldehyde
raceMic-Tasocitinib
1,3-bis((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)propane-1,3-dione